---
layout: default
title: Polymyxin B
description: "Polymyxin B çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 3 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 132
evidence_level: L1
indication_count: 3
---

# Polymyxin B

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>3</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Polymyxin B (å¤šé»èŒç´ B) - è—¥å¸«è©•ä¼°å ±å‘Š

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Polymyxin B å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
å¤šé»èŒç´ Bæ˜¯ä¸€ç¨®æŠ—é©è˜­æ°é™°æ€§èŒçš„å¤šè‚½é¡æŠ—ç”Ÿç´ ,TxGNNé æ¸¬å…¶å¯ç”¨æ–¼æ”¯æ°£ç®¡ç‚å’Œçµè†œç‚,å…¶ä¸­çµè†œç‚å·²æœ‰Phase 3/4è‡¨åºŠè©¦é©—æ”¯æŒ,æ”¯æ°£ç®¡ç‚å‰‡æœ‰è±å¯Œçš„æ–‡ç»è­‰æ“šæ”¯æŒå¸å…¥å¼æ²»ç™‚ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Polymyxin B (å¤šé»èŒç´ B) |
| DrugBank ID | DB00781 |
| å°ç£å“ç‰Œå | åœ°éˆé»´ç´ çœ¼è—¥è†ç­‰å¤šç¨®çœ¼ç”¨è£½åŠ‘ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | ç´°èŒæ€§çœ¼éƒ¨æ„ŸæŸ“ã€çµè†œç‚ã€è§’è†œç‚ã€çš®è†šæ„ŸæŸ“ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | bronchitisã€laryngotracheitisã€conjunctivitis |
| æœ€é«˜è­‰æ“šç­‰ç´š | L2 (å–®ä¸€RCT/å¤šå€‹Phase 2) |
| è‡¨åºŠè©¦é©—æ•¸ | 3é … (çµè†œç‚ç›¸é—œ) |
| æ–‡ç»æ”¯æŒ | 14ç¯‡ (æ”¯æ°£ç®¡ç‚ç›¸é—œ) |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. bronchitis</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.87%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>### æ”¯æ°£ç®¡ç‚é æ¸¬åˆ†æ (TxGNN Score: 0.999, Rank: 3514)</p>

<ol>
<li><strong>æŠ—èŒæ©Ÿåˆ¶</strong>: Polymyxin Bå°é©è˜­æ°é™°æ€§èŒ(å¦‚ç¶ è†¿æ¡¿èŒã€é®‘æ°ä¸å‹•æ¡¿èŒ)å…·å¼·æ•ˆæ®ºèŒä½œç”¨</li>
<li><strong>å‘¼å¸é“æ„ŸæŸ“é—œè¯</strong>: é€™äº›ç—…åŸèŒæ˜¯å‘¼å¸æ©Ÿç›¸é—œè‚ºç‚å’Œæ°£ç®¡æ”¯æ°£ç®¡ç‚çš„ä¸»è¦è‡´ç—…èŒ</li>
<li><strong>å¸å…¥çµ¦è—¥ç¶“é©—</strong>: å·²æœ‰å¸å…¥å¼polymyxin Bç”¨æ–¼å¤šé‡æŠ—è—¥æ€§èŒæ„ŸæŸ“çš„è‡¨åºŠç¶“é©—</li>
<li><strong>æŠ—è—¥æ€§è€ƒé‡</strong>: ä½œç‚ºæœ€å¾Œé˜²ç·šæŠ—ç”Ÿç´ ,å°å¤šé‡æŠ—è—¥æ€§èŒæ ªæœ‰æ•ˆ</li>
</ol>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

<h3>ç›¸é—œæ–‡ç»</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23124906/" target="_blank">23124906</a></td><td>2013</td><td>Article</td><td>Infection</td><td>Comparison of polymyxin B with other antimicrobials in the treatment of ventilat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/231152/" target="_blank">231152</a></td><td>1979</td><td>Article</td><td>Lung</td><td>Bronchial reactivity to inhaled polymyxin B in subjects with asthma and chronic ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17350201/" target="_blank">17350201</a></td><td>2007</td><td>Article</td><td>Diagnostic microbiology and in</td><td>Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4319158/" target="_blank">4319158</a></td><td>1970</td><td>Article</td><td>Chest</td><td>Endobronchial Polymyxin B: experimental observations in chronic bronchitis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28441858/" target="_blank">28441858</a></td><td>2017</td><td>Article</td><td>Zhonghua yi xue za zhi</td><td>[Development of an eosinophilic bronchitis mouse model and the effects of eosino...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11359434/" target="_blank">11359434</a></td><td>2001</td><td>Article</td><td>Clinical and experimental alle</td><td>In vivo airway eosinophil accumulation induced by polymyxin-B reduces bronchial ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8054833/" target="_blank">8054833</a></td><td>1994</td><td>Article</td><td>Clinical autonomic research : </td><td>The effect of the neurokinin antagonist FK-224 on the cough response to inhaled ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2984629/" target="_blank">2984629</a></td><td>1985</td><td>Article</td><td>Orvosi hetilap</td><td>[Polymyxin B sulfate-induced non-specific bronchial provocation in bronchial ast...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4373513/" target="_blank">4373513</a></td><td>1974</td><td>Article</td><td>The Journal of the Kansas Medi</td><td>Pseudomonas tracheobronchitis. The use of systemic gentamicin and polymyxin-B ae...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7402949/" target="_blank">7402949</a></td><td>1980</td><td>Article</td><td>Pneumonologia polska</td><td>[Exercise-induced bronchospasm versus the histamine and polymyxin B provocation ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4322737/" target="_blank">4322737</a></td><td>1971</td><td>Article</td><td>Annals of internal medicine</td><td>Danger of polymyxin B inhalation.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12358343/" target="_blank">12358343</a></td><td>2002</td><td>Article</td><td>The European respiratory journ</td><td>Neutrophil survival is prolonged in the airways of healthy infants and infants w...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11376364/" target="_blank">11376364</a></td><td>2000</td><td>Article</td><td>Saudi medical journal</td><td>Isolation of Moraxella catarrhalis in patients at King Khalid University Hospita...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6990166/" target="_blank">6990166</a></td><td>1980</td><td>Article</td><td>Medycyna pracy</td><td>[Need to consider various factors predisposing to chronic nonspecific lung disea...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. laryngotracheitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.62%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. conjunctivitis</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.06%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ3 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01227863" target="_blank">NCT01227863</a></td><td>PHASE3</td><td>UNKNOWN</td><td>70</td><td>Randomized Clinical Trial Of Drug Topics Efficacy MaxinomÂ® (Dexamethasone + Neom...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00581542" target="_blank">NCT00581542</a></td><td>PHASE4</td><td>COMPLETED</td><td>124</td><td>A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxif...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01809483" target="_blank">NCT01809483</a></td><td>PHASE3</td><td>COMPLETED</td><td>32</td><td>Comparison Between Bandage Contact Lens and Pressure Patching for The Erosion Ar...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31535057/" target="_blank">31535057</a></td><td>2019</td><td>Article</td><td>American journal of ophthalmol</td><td>Dupilumab-associated blepharoconjunctivitis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19043943/" target="_blank">19043943</a></td><td>2008</td><td>Article</td><td>Journal of pediatric ophthalmo</td><td>Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conj...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19043945/" target="_blank">19043945</a></td><td>2008</td><td>Article</td><td>Journal of pediatric ophthalmo</td><td>A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14686993/" target="_blank">14686993</a></td><td>2003</td><td>Article</td><td>Clinical microbiology and infe</td><td>Primary meningococcal conjunctivitis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23092529/" target="_blank">23092529</a></td><td>2013</td><td>Article</td><td>The Journal of pediatrics</td><td>A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim an...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/6188739/" target="_blank">6188739</a></td><td>1983</td><td>Article</td><td>The Journal of antimicrobial c</td><td>Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bac...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28242882/" target="_blank">28242882</a></td><td>2016</td><td>Article</td><td>Nepalese journal of ophthalmol</td><td>Acute bacterial conjunctivitis - antibiotic susceptibility and resistance to com...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2850891/" target="_blank">2850891</a></td><td>1988</td><td>Article</td><td>Current medical research and o</td><td>Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacter...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8595639/" target="_blank">8595639</a></td><td>1995</td><td>Article</td><td>Clinical therapeutics</td><td>Results of a survey of children with acute bacterial conjunctivitis treated with...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26922212/" target="_blank">26922212</a></td><td>2016</td><td>Article</td><td>Annals of allergy, asthma &amp; im</td><td>Anaphylaxis to polymyxin B-trimethoprim eye drops.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2540136/" target="_blank">2540136</a></td><td>1989</td><td>Article</td><td>The Journal of antimicrobial c</td><td>Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol oph...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2370842/" target="_blank">2370842</a></td><td>1990</td><td>Article</td><td>The Medical letter on drugs an</td><td>Trimethoprim-polymyxin B for bacterial conjunctivitis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16491721/" target="_blank">16491721</a></td><td>2006</td><td>Article</td><td>Journal of pediatric ophthalmo</td><td>Controlling contagious bacterial conjunctivitis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35776393/" target="_blank">35776393</a></td><td>2023</td><td>Article</td><td>International ophthalmology</td><td>Indication-prescription study for the management of conjunctivitis in a Colombia...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7671609/" target="_blank">7671609</a></td><td>1995</td><td>Article</td><td>Cornea</td><td>An in vitro comparison of the susceptibilities of bacterial isolates from patien...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/184771/" target="_blank">184771</a></td><td>1976</td><td>Article</td><td>Archives of ophthalmology (Chi</td><td>Human conjunctivitis. II. Treatment.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/13076751/" target="_blank">13076751</a></td><td>1953</td><td>Article</td><td>The South Dakota journal of me</td><td>Bacteriological studies in new borns using terramycin, terramycin-polymyxin-B an...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1286241/" target="_blank">1286241</a></td><td>1992</td><td>Article</td><td>Optometry clinics : the offici</td><td>New antibacterial drugs for topical ophthalmic use.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11270936/" target="_blank">11270936</a></td><td>2001</td><td>Article</td><td>Drugs</td><td>Comparative review of topical ophthalmic antibacterial preparations.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2418736/" target="_blank">2418736</a></td><td>1985</td><td>Article</td><td>Annals of ophthalmology</td><td>Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bact...</td></tr>
</tbody>
</table>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

### ç¾æœ‰æ ¸å‡†è£½åŠ‘

å°ç£å·²æœ‰å¤šç¨®å«Polymyxin Bçš„çœ¼ç”¨è¤‡æ–¹è£½åŠ‘,ä¸»è¦é©æ‡‰ç—‡ç‚º:
- ç´°èŒæ€§çœ¼éƒ¨æ„ŸæŸ“
- æ€¥æ…¢æ€§çµè†œç‚
- è§’è†œç‚ã€è§’è†œæ½°ç˜
- çœ¼ç¼ç‚ã€æ·šå›Šç‚

### åŠ‘å‹åˆ†å¸ƒ
- çœ¼è—¥è†/çœ¼è—¥æ°´ (ä¸»è¦)
- å¤–ç”¨è»Ÿè†
- è€³ç”¨è£½åŠ‘

## å®‰å…¨æ€§è€ƒé‡

### å·²çŸ¥å®‰å…¨æ€§è³‡è¨Š

1. **è…æ¯’æ€§**: å…¨èº«æ€§ä½¿ç”¨æœ‰è…æ¯’æ€§é¢¨éšª,éœ€ç›£æ¸¬è…åŠŸèƒ½
2. **ç¥ç¶“æ¯’æ€§**: å¯èƒ½å¼•èµ·ç¥ç¶“è‚Œè‚‰é˜»æ–·
3. **éæ•åæ‡‰**: å¸å…¥çµ¦è—¥å¯èƒ½å¼•èµ·æ”¯æ°£ç®¡ç—™æ”£
4. **å±€éƒ¨åˆºæ¿€**: çœ¼ç”¨è£½åŠ‘å¯èƒ½å¼•èµ·çŸ­æš«åˆºæ¿€

### å¸å…¥çµ¦è—¥ç‰¹æ®Šè€ƒé‡

1. **æ”¯æ°£ç®¡ç—™æ”£é¢¨éšª**: æ–‡ç»å ±å‘Šå¸å…¥å¾Œå¯èƒ½èª˜ç™¼æ”¯æ°£ç®¡æ”¶ç¸®
2. **éœ§åŒ–å‰è™•ç†**: å»ºè­°å…ˆä½¿ç”¨æ”¯æ°£ç®¡æ“´å¼µåŠ‘
3. **ç›£æ¸¬éœ€æ±‚**: éœ€å¯†åˆ‡ç›£æ¸¬å‘¼å¸åŠŸèƒ½

### è—¥ç‰©äº¤äº’ä½œç”¨

DDIè³‡æ–™åº«æœªè¨˜è¼‰é¡¯è‘—äº¤äº’ä½œç”¨,ä½†æ‡‰æ³¨æ„:
- èˆ‡å…¶ä»–è…æ¯’æ€§è—¥ç‰©ä½µç”¨éœ€è¬¹æ…
- èˆ‡ç¥ç¶“è‚Œè‚‰é˜»æ–·åŠ‘å¯èƒ½æœ‰åŠ æˆä½œç”¨


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Colitis** ğŸŸ¢ Minor
- é¢¨éšªåŒ…æ‹¬ï¼šæ„ŸæŸ“ã€‚å¯èƒ½æœ‰è‡´å‘½é¢¨éšªã€‚

**è…è‡Ÿç–¾ç—…** ğŸŸ¢ Minor
- æ‡‰é¿å…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šè…æ¯’æ€§ã€ç¥ç¶“æ¯’æ€§ã€‚å‡ºç¾ç—‡ç‹€æ™‚æ‡‰è€ƒæ…®åœè—¥ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### æ•´é«”è©•ä¼°

| è©•ä¼°é …ç›® | æ”¯æ°£ç®¡ç‚ | çµè†œç‚ |
|----------|----------|--------|
| è­‰æ“šç­‰ç´š | L3 (è§€å¯Ÿæ€§ç ”ç©¶) | L2 (Phase 3/4) |
| æ©Ÿåˆ¶åˆç†æ€§ | é«˜ | é«˜ (å·²æ ¸å‡†) |
| è‡¨åºŠå¯è¡Œæ€§ | ä¸­ (é™ç‰¹å®šæ‚£è€…ç¾¤) | é«˜ |
| å»ºè­°å„ªå…ˆé †åº | ä¸­ | å·²å¯¦ç¾ |

### å»ºè­°

**æ”¯æ°£ç®¡ç‚é©æ‡‰ç—‡**:
1. **é©ç”¨æ—ç¾¤**: å¤šé‡æŠ—è—¥æ€§é©è˜­æ°é™°æ€§èŒå¼•èµ·çš„å‘¼å¸é“æ„ŸæŸ“
2. **çµ¦è—¥é€”å¾‘**: å¸å…¥å¼éœ§åŒ–çµ¦è—¥
3. **é€²ä¸€æ­¥ç ”ç©¶**: å»ºè­°é€²è¡Œå‰ç»æ€§éš¨æ©Ÿå°ç…§è©¦é©—
4. **è‡¨åºŠå®šä½**: ä½œç‚ºå¤šé‡æŠ—è—¥æ€§æ„ŸæŸ“çš„æ•‘æ´æ€§æ²»ç™‚é¸é …

**çµè†œç‚é©æ‡‰ç—‡**:
- å·²æœ‰å……åˆ†è­‰æ“šæ”¯æŒ,ç›®å‰æ ¸å‡†é©æ‡‰ç—‡æ¶µè“‹æ­¤ç”¨é€”

### é™åˆ¶èªªæ˜

- å¸å…¥å¼çµ¦è—¥åœ¨å°ç£å°šç„¡å°ˆç”¨è£½åŠ‘
- æ”¯æ°£ç®¡ç‚æ–‡ç»å¤šç‚ºæ•‘æ´æ€§æ²»ç™‚,éç¬¬ä¸€ç·šç”¨è—¥
- éœ€è€ƒæ…®æŠ—è—¥æ€§ç®¡ç†ç­–ç•¥

---
*å ±å‘Šç”¢ç”Ÿæ—¥æœŸ: 2026-02-11*
*è³‡æ–™ä¾†æº: TxGNNé æ¸¬ã€ClinicalTrials.govã€PubMedã€å°ç£é£Ÿå“è—¥ç‰©ç®¡ç†ç½²*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Tyrosine]({{ "/drugs/tyrosine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Tinidazole]({{ "/drugs/tinidazole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Pentoxifylline]({{ "/drugs/pentoxifylline/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Amorolfine]({{ "/drugs/amorolfine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Buprenorphine]({{ "/drugs/buprenorphine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Polymyxin Bè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/polymyxin_b/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_polymyxin_b,
  title = {Polymyxin Bè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/polymyxin_b/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
